BIOMAT Database Logo BIOMAT Database Logo

Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice by heparin. 1990

Y Naparstek, and A Ben-Yehuda, and M P Madaio, and R Bar-Tana, and L Schuger, and G Pizov, and Z V Neeman, and I R Cohen
Hadassah University Hospital, Jerusalem, Israel.

Heparin was found to inhibit the DNA binding of antibodies eluted from kidneys of both humans and MRL-lpr/lpr mice with systemic lupus erythematosus. Treatment of MRL-lpr/lpr mice with low doses of heparin significantly inhibited renal damage. These results suggest that low-dose heparin might be useful in preventing renal damage in patients with lupus nephritis.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008181 Lupus Nephritis Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982). Glomerulonephritis, Lupus,Lupus Glomerulonephritis,Nephritis, Lupus,Glomerulonephritides, Lupus,Lupus Glomerulonephritides,Lupus Nephritides,Nephritides, Lupus
D009394 Nephritis, Hereditary A group of inherited conditions characterized initially by HEMATURIA and slowly progressing to RENAL INSUFFICIENCY. The most common form is the Alport syndrome (hereditary nephritis with HEARING LOSS) which is caused by mutations in genes for TYPE IV COLLAGEN and defective GLOMERULAR BASEMENT MEMBRANE. Alport's Syndrome,Nephritis, Familial,Alport Syndrome,Alport Syndrome, Autosomal Dominant,Alport Syndrome, Autosomal Recessive,Alport Syndrome, X-Linked,Congenital Hereditary Hematuria,Hematuria-Nephropathy-Deafness Syndrome,Hematuric Hereditary Nephritis,Hemorrhagic Familial Nephritis,Hemorrhagic Hereditary Nephritis,Hereditary Familial Congenital Hemorrhagic Nephritis,Hereditary Hematuria Syndrome,Hereditary Interstitial Pyelonephritis,Hereditary Nephritis,Alport Syndrome, X Linked,Familial Nephritis,Hematuria Nephropathy Deafness Syndrome,Hematuria, Congenital Hereditary,Nephritis, Hematuric Hereditary,Nephritis, Hemorrhagic Familial,Nephritis, Hemorrhagic Hereditary,Pyelonephritis, Hereditary Interstitial,Syndrome, Alport,Syndrome, Hematuria-Nephropathy-Deafness,X-Linked Alport Syndrome
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Y Naparstek, and A Ben-Yehuda, and M P Madaio, and R Bar-Tana, and L Schuger, and G Pizov, and Z V Neeman, and I R Cohen
Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
August 2010, Arthritis and rheumatism,
Y Naparstek, and A Ben-Yehuda, and M P Madaio, and R Bar-Tana, and L Schuger, and G Pizov, and Z V Neeman, and I R Cohen
IgG binding of monoclonal anti-nuclear antibodies from MRL-lpr/lpr mice.
December 1990, Immunology,
Y Naparstek, and A Ben-Yehuda, and M P Madaio, and R Bar-Tana, and L Schuger, and G Pizov, and Z V Neeman, and I R Cohen
Structural patterns in anti-DNA antibodies from MRL/lpr mice.
January 1989, Cold Spring Harbor symposia on quantitative biology,
Y Naparstek, and A Ben-Yehuda, and M P Madaio, and R Bar-Tana, and L Schuger, and G Pizov, and Z V Neeman, and I R Cohen
Specificity of monoclonal anti-Z-DNA antibodies from unimmunized MRL/Mp-lpr/lpr mice.
August 1987, Journal of immunology (Baltimore, Md. : 1950),
Y Naparstek, and A Ben-Yehuda, and M P Madaio, and R Bar-Tana, and L Schuger, and G Pizov, and Z V Neeman, and I R Cohen
The emergence of anti-dsDNA antibodies precedes nucleosome-specific antibodies in MRL/lpr and MRL/+ mice.
March 2003, Journal of medical and dental sciences,
Y Naparstek, and A Ben-Yehuda, and M P Madaio, and R Bar-Tana, and L Schuger, and G Pizov, and Z V Neeman, and I R Cohen
Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice.
February 1993, Journal of immunology (Baltimore, Md. : 1950),
Y Naparstek, and A Ben-Yehuda, and M P Madaio, and R Bar-Tana, and L Schuger, and G Pizov, and Z V Neeman, and I R Cohen
The heart and antiphospholipid antibodies in MRL-lpr/lpr mice.
December 1992, Lupus,
Y Naparstek, and A Ben-Yehuda, and M P Madaio, and R Bar-Tana, and L Schuger, and G Pizov, and Z V Neeman, and I R Cohen
Inhibitory oligodeoxynucleotide improves glomerulonephritis and prolongs survival in MRL-lpr/lpr mice.
December 2007, Fukushima journal of medical science,
Y Naparstek, and A Ben-Yehuda, and M P Madaio, and R Bar-Tana, and L Schuger, and G Pizov, and Z V Neeman, and I R Cohen
Parallel sets of autoantibodies in MRL-lpr/lpr mice. An anti-DNA, anti-SmRNP, anti-gp70 network.
February 1987, The Journal of experimental medicine,
Y Naparstek, and A Ben-Yehuda, and M P Madaio, and R Bar-Tana, and L Schuger, and G Pizov, and Z V Neeman, and I R Cohen
Selection of anti-double-stranded DNA B cells in autoimmune MRL-lpr/lpr mice.
May 2006, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!